Updates from The Motley Fool

Latest updates on VIVUS, Inc. from Fool.com.


Stock Performance

VVUS vs. S&P 500 | 2 Year Performance
VVUS 1-Day Stock Chart
VVUS 5-Day Stock Chart
VVUS 1-Month Stock Chart
VVUS 3-Month Stock Chart
VVUS 6-Month Stock Chart
VVUS 1-Year Stock Chart
VVUS 2-Year Stock Chart
VVUS 5-Year Stock Chart
View Interactive VVUS Charts
Sponsored by

Key Data Points

Primary metrics and data points about VIVUS, Inc..
Current Price: $1.50
Prev Close: $1.58
Open: $1.58
Bid: $1.45
Ask: $1.50
Day's Range: $1.50 - $1.60
52wk Range: $0.92 - $2.65
Volume: 649,714
Avg Vol 1,179,104
Market Cap: $156.05M
P/E (ttm): -1.76
EPS (ttm): -$0.90
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about VIVUS, Inc..
CAPS Rating 2 out of 5
 
345 Outperform
70 Underperform
CAPS All Stars
 
48 Outperform
23 Underperform

How do you think VIVUS, Inc. will perform against the market?



You pick for VIVUS, Inc. is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Leland F. Wilson, CEO

27% Approve

Based on 4 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for VIVUS, Inc..

A pharmaceutical company dedicated to the development and commercialization of therapeutic products using patented proprietary formulations and novel delivery systems and by seeking new indications for previously approved pharmaceutical products.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers